Abstract
One new neolignan, racelactone A (1), together with seven known compounds (2-8) were isolated from the methanolic extract of the leaves and twigs of Lumnitzera racemosa. The structure of racelactone A (1) was determined on the basis of the mass and NMR spectroscopic data interpretation. With respect to bioactivity, compound 1 displayed an anti-angiogenic effect by suppressing tube formation. Furthermore, compounds 1, 4, and 5 showed significant anti-inflammatory effects with IC50 values of 4.95 ± 0.89, 1.95 ± 0.40, and 2.57 ± 0.23 μM, respectively. The plausible biosynthesis pathway of racelactone A (1) was proposed.
Keywords:
Lumnitzera racemosa; anti-angiogenesis; anti-inflammation; neolignan.
MeSH terms
-
Angiogenesis Inhibitors / chemistry*
-
Angiogenesis Inhibitors / isolation & purification
-
Angiogenesis Inhibitors / pharmacology*
-
Anti-Inflammatory Agents / chemistry*
-
Anti-Inflammatory Agents / isolation & purification
-
Anti-Inflammatory Agents / pharmacology*
-
Apoptosis / drug effects
-
Avicennia
-
Combretaceae / chemistry*
-
Endothelial Progenitor Cells / drug effects
-
Humans
-
Lignans / chemistry*
-
Lignans / isolation & purification
-
Lignans / pharmacology*
-
Magnetic Resonance Spectroscopy
-
Plant Extracts / chemistry
-
Plant Extracts / isolation & purification
-
Plant Extracts / pharmacology
-
Plant Leaves / chemistry
Substances
-
Angiogenesis Inhibitors
-
Anti-Inflammatory Agents
-
Lignans
-
Plant Extracts